高级检索
当前位置: 首页 > 详情页

lncRNA mortal obligate RNA transcript was downregulated in ovarian carcinoma and inhibits cancer cell proliferation by downregulating miRNA-21

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Rehabilitation Medicine, Guangzhou Panyu Central Hospital, Guangzhou, P.R. China [2]Department of Oncology, Guangdong Provincial Hospital of Traditional Chinese Medicine, Guangzhou, P.R. China [3]Department of Oncology, Guangzhou Panyu Central Hospital, Guangzhou, P.R. China [4]School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, P.R. China
出处:
ISSN:

关键词: long noncoding RNA Mortal Obligate RNA Transcript microRNA-21 ovarian carcinoma proliferation

摘要:
microRNA-21 (miRNA-21) is a well-characterized oncogenic miRNA in human cancers. In the present study, we found that miRNA-21 was upregulated, while long noncoding RNA Mortal Obligate RNA Transcript (lncRNA MORT), which has been reported to be silenced in 16 types of cancers, was downregulated in tumor tissues than in adjacent healthy tissues of patients with ovarian carcinoma. Expression of lncRNA MORT in tumor tissues was found to be significantly affected by tumor size but not by tumor metastasis. Expression levels of lncRNA MORT and miRNA-21 were significantly and inversely correlated in both tumor tissues and adjacent healthy tissues. Overexpression of lncRNA MORT inhibited miRNA-21, while miRNA-21 overexpression failed to significantly affect lncRNA MORT expression. Overexpression of lncRNA MORT inhibited, while miRNA-21 overexpression promoted the proliferation of cells of ovarian cancer cell lines. In addition, miRNA-21 overexpression partially reversed the inhibitory effects of lncRNA MORT overexpression on cancer cell proliferation. However, overexpression of lncRNA MORT showed no significant effects on cancer cell migration and invasion. Therefore, lncRNA MORT was downregulated in ovarian carcinoma and lncRNA MORT overexpression inhibited cancer cell proliferation, possibly by downregulating miRNA-21.

语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 3 区 生物
小类 | 3 区 生化与分子生物学 4 区 细胞生物学
最新[2025]版:
大类 | 3 区 生物学
小类 | 4 区 生化与分子生物学 4 区 细胞生物学
JCR分区:
出版当年[2017]版:
Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Q3 CELL BIOLOGY
最新[2023]版:
Q3 BIOCHEMISTRY & MOLECULAR BIOLOGY Q3 CELL BIOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者机构: [1]Department of Rehabilitation Medicine, Guangzhou Panyu Central Hospital, Guangzhou, P.R. China
通讯作者:
通讯机构: [1]Department of Rehabilitation Medicine, Guangzhou Panyu Central Hospital, Guangzhou, P.R. China [*1]Department of Rehabilitation Medicine, Guangzhou Panyu Central Hospital, No. 8 Yudong Road, Guangzhou, 511400 Guangdong, PR. China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2018 今日访问量:0 总访问量:645 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号